Cargando…
Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001
For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719288/ https://www.ncbi.nlm.nih.gov/pubmed/31508511 http://dx.doi.org/10.1016/j.synbio.2019.08.002 |
_version_ | 1783447907325706240 |
---|---|
author | Devi, Sagarika Kiesewalter, Heiko T. Kovács, Renátó Frisvad, Jens Christian Weber, Tilmann Larsen, Thomas Ostenfeld Kovács, Ákos T. Ding, Ling |
author_facet | Devi, Sagarika Kiesewalter, Heiko T. Kovács, Renátó Frisvad, Jens Christian Weber, Tilmann Larsen, Thomas Ostenfeld Kovács, Ákos T. Ding, Ling |
author_sort | Devi, Sagarika |
collection | PubMed |
description | For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the antifungal efficacy, extracts of B. velezensis DTU001 was tested against a range of twenty human or plant pathogenic fungi. We demonstrate that inhibitory potential of B. velezensis DTU001 against selected fungi is superior in comparison to single lipopeptide, either iturin or fengycin. The isolate showed analogous biofilm formation to other closely related Bacilli. To further support the biocontrol properties of the isolate, coculture with Candida albicans demonstrated that B. velezensis DTU001 exhibited excellent antiproliferation effect against C. albicans. In summary, the described isolate is a potential antifungal agent with a broad antifungal spectrum that might assist our aims to avoid hazardous pathogenic fungi and provide alternative to toxicity caused by chemicals. |
format | Online Article Text |
id | pubmed-6719288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-67192882019-09-10 Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 Devi, Sagarika Kiesewalter, Heiko T. Kovács, Renátó Frisvad, Jens Christian Weber, Tilmann Larsen, Thomas Ostenfeld Kovács, Ákos T. Ding, Ling Synth Syst Biotechnol Article For a safe and sustainable environment, effective microbes as biocontrol agents are in high demand. We have isolated a new Bacillus velezensis strain DTU001, investigated its antifungal spectrum, sequenced its genome, and uncovered the production of lipopeptides in HPLC-HRMS analysis. To test the antifungal efficacy, extracts of B. velezensis DTU001 was tested against a range of twenty human or plant pathogenic fungi. We demonstrate that inhibitory potential of B. velezensis DTU001 against selected fungi is superior in comparison to single lipopeptide, either iturin or fengycin. The isolate showed analogous biofilm formation to other closely related Bacilli. To further support the biocontrol properties of the isolate, coculture with Candida albicans demonstrated that B. velezensis DTU001 exhibited excellent antiproliferation effect against C. albicans. In summary, the described isolate is a potential antifungal agent with a broad antifungal spectrum that might assist our aims to avoid hazardous pathogenic fungi and provide alternative to toxicity caused by chemicals. KeAi Publishing 2019-08-27 /pmc/articles/PMC6719288/ /pubmed/31508511 http://dx.doi.org/10.1016/j.synbio.2019.08.002 Text en © 2019 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Devi, Sagarika Kiesewalter, Heiko T. Kovács, Renátó Frisvad, Jens Christian Weber, Tilmann Larsen, Thomas Ostenfeld Kovács, Ákos T. Ding, Ling Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title_full | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title_fullStr | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title_full_unstemmed | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title_short | Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001 |
title_sort | depiction of secondary metabolites and antifungal activity of bacillus velezensis dtu001 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719288/ https://www.ncbi.nlm.nih.gov/pubmed/31508511 http://dx.doi.org/10.1016/j.synbio.2019.08.002 |
work_keys_str_mv | AT devisagarika depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT kiesewalterheikot depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT kovacsrenato depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT frisvadjenschristian depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT webertilmann depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT larsenthomasostenfeld depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT kovacsakost depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 AT dingling depictionofsecondarymetabolitesandantifungalactivityofbacillusvelezensisdtu001 |